| Random sequence generation (selection bias) |
Unclear risk |
Quote: “.participants were randomised by the trial statistician (MS) into two groups” |
| Comment: Insufficient information to permit judgement |
| Allocation concealment (selection bias) |
Unclear risk |
Quote: “.participants were randomised by the trial statistician (MS) into two groups” |
| Comment: Insufficient information to permit judgement |
| Blinding of participants and personnel (performance bias) |
Low risk |
Quote: “local pharmacist prepared tablets which were identical in number, colour, size and texture to the ergocalciferol, but contained only sucrose.” |
| Comment: Adequately done |
| Blinding of outcome assessment (detection bias) |
Low risk |
Quote: “All the primary investigators of the study were totally blinded to the treatment regimen.” |
| Comment: Adequately done. |
| Incomplete outcome data (attrition bias) |
Low risk |
Comment: |
| Group 1: No loss to follow‐up. |
| Group 2: 1/50 loss to follow‐up. |
| Selective reporting (reporting bias) |
Unclear risk |
Comment: Trial registration not reported. Outcomes specified in the methodology section were reported |
| Other bias |
Low risk |
Comment: No other biases detected. |